Science Strategic Acquisition Alpha - Warrants (20/01/2026) EBIT

The latest EBIT for SSAAW is $1.8B as of September 2022. That compares with $-940K in the prior-year period — up 191560.5% year over year. That is above the sector sector average of $-77M. Investors often review this figure alongside Science Strategic Acquisition Alpha - Warrants (20/01/2026)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, SSAAW's EBIT moved from $-940K to $1.8B — a 191560.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Science Strategic Acquisition Alpha - Warrants (20/01/2026)'s operating scale or balance-sheet position.

Against its sector companies, SSAAW currently prints $1.8B for EBIT, while the sector average sits near $-77M. That is roughly 2461.0% above the sector mean. Large gaps often invite a closer look at Science Strategic Acquisition Alpha - Warrants (20/01/2026)'s growth, margins, and balance sheet.

A EBIT figure of $1.8B for SSAAW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $-77M. Explore the charts below for those layers of context.

After noting SSAAW's EBIT ($1.8B), review year-over-year change from $-940K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.